# Strategic Capital Deployment in Animal Health & Agrifood_ Expanded Fund Analysis.docx

# Strategic Capital Deployment in the Global Animal Health and Agrifood Ecosystems: An Exhaustive Analysis of Private Equity and Venture Capital Portfolios

## 1. Executive Introduction

The convergence of animal health, veterinary medicine, and advanced agrifood systems represents one of the most dynamic frontiers in global capital allocation. Over the past decade, the investment thesis for these sectors has evolved from niche plays into central pillars of value creation for some of the world's largest asset managers. This transformation is driven by three powerful secular trends: the "humanization" of companion animals, which necessitates human-grade healthcare and nutrition; the imperative for sustainable protein production to feed a growing global population; and the digitization of biological workflows.

This report provides a comprehensive, expert-level analysis of a specific cohort of Venture Capital (VC) and Private Equity (PE) funds that are actively shaping this landscape. The funds analyzed range from specialized, early-stage investors like Digitalis Ventures and Ani.VC—who fund high-risk, high-reward deep science—to massive global buyout firms like EQT and Morgan Stanley Capital Partners, who are consolidating fragmented service markets and verticalizing entire industries.

Collectively, the funds analyzed herein manage hundreds of billions of dollars in assets, with specific multi-billion dollar allocations directed toward the companies detailed in this report. By dissecting the portfolios of these firms, we observe a clear bifurcation in strategy: VCs are funding the "software" of biology (genomics, microbiome, precision fermentation), while PEs are optimizing the "hardware" (clinics, hospitals, manufacturing, and logistics).

The following sections detail the Assets Under Management (AUM), investment philosophies, and granular portfolio compositions for each fund. Per the research mandate, every identified portfolio company is classified by sector (Veterinary vs. Other) and analyzed for its specific involvement in Pet Food and Nutraceuticals.

## 2. Digitalis Ventures

### 2.1. Fund Overview and Assets Under Management (AUM)

Digitalis Ventures is a venture capital firm headquartered in New York City that operates at the intersection of math, physics, computing, chemistry, and biology. The firm manages approximately $925 million in assets under management (AUM). Digitalis is unique in its structural approach to the animal health market; it manages the Companion Fund, a corporate venture capital arrangement backed by Mars Petcare.

This partnership allows Digitalis to deploy capital with the financial discipline of a traditional VC while offering portfolio companies access to the immense operational resources, distribution networks, and R&D capabilities of Mars, one of the world's largest pet care entities. The firm recently launched Companion Fund II, a $300 million vehicle designed to back founders leveraging breakthrough science to improve the lives of pets, pet owners, and veterinarians. This follows the success of the initial $100 million fund.

### 2.2. Portfolio Architecture and Analysis

The Digitalis portfolio is characterized by "deep science." Unlike consumer-only funds, Digitalis invests heavily in therapeutics, diagnostics, and advanced computation.

#### Table 1: Digitalis Ventures Portfolio Analysis

## 3. Ani.VC

### 3.1. Fund Overview and Assets Under Management (AUM)

Ani.VC is a specialist venture capital firm launched in 2024 to capitalize on the "Pet Economy."

AUM: The fund has announced a capital deployment target of $35 million over its first three years.

Investment Thesis: Ani.VC explicitly targets the "Pet Longevity" and "Pet Lifestyle" verticals, filling the gap for pre-PE startups requiring sector expertise.

### 3.2. Portfolio Architecture and Analysis

#### Table 2: Ani.VC Portfolio Analysis

## 4. Stray Dog Capital

### 4.1. Fund Overview and Assets Under Management (AUM)

Stray Dog Capital is a mission-driven venture capital firm investing in the future of food, specifically the removal of animals from the supply chain.

AUM: Approximately $90 million across multiple funds.

### 4.2. Portfolio Architecture and Analysis

#### Table 3: Stray Dog Capital Portfolio Analysis (Select Relevant Investments)

## 5. Borealis Ventures

### 5.1. Fund Overview and Assets Under Management (AUM)

Borealis Ventures is an early-stage venture firm based in Hanover, NH, focused on healthcare and the built environment.

AUM: Less than $150 million.

### 5.2. Portfolio Architecture and Analysis

#### Table 4: Borealis Ventures Portfolio Analysis

## 6. S2G Investments (Seed to Growth)

### 6.1. Fund Overview and Assets Under Management (AUM)

S2G Investments is a multi-stage firm focused on food, agriculture, oceans, and clean energy.

AUM: Approximately $2.5 Billion.

### 6.2. Portfolio Architecture and Analysis

#### Table 5: S2G Investments Portfolio Analysis (Relevant Selections)

## 7. Tyson Ventures

### 7.1. Fund Overview and Assets Under Management (AUM)

Tyson Ventures is the corporate venture capital arm of Tyson Foods.

AUM: Invests off the corporate balance sheet; initial allocation $100 million (flexible).

### 7.2. Portfolio Architecture and Analysis

#### Table 6: Tyson Ventures Portfolio Analysis

## 8. Seventure Partners (AVF & Health for Life)

### 8.1. Fund Overview and Assets Under Management (AUM)

Seventure Partners is a French VC firm, a subsidiary of Natixis, leading in microbiome investing.

AUM: Total AUM ~€1 billion ($1.1B).

Specific Funds: Health for Life Capital™ (Microbiome) and AVF (Animal Health/Nutrition - €24M).

### 8.2. Portfolio Architecture and Analysis

#### Table 7: Seventure Partners Portfolio Analysis

## 9. Gryphon Investors

### 9.1. Fund Overview and Assets Under Management (AUM)

Gryphon Investors is a middle-market PE firm based in San Francisco.

AUM: Approximately $9 billion.

### 9.2. Portfolio Architecture and Analysis

#### Table 8: Gryphon Investors Portfolio Analysis

## 10. Morgan Stanley Capital Partners (MSCP)

### 10.1. Fund Overview and Assets Under Management (AUM)

MSCP is the middle-market PE team within Morgan Stanley Investment Management ($1.5T+ AUM).

### 10.2. Portfolio Architecture and Analysis

#### Table 9: Morgan Stanley Capital Partners Portfolio Analysis

## 11. EQT Group

### 11.1. Fund Overview and Assets Under Management (AUM)

EQT is a global investment organization based in Sweden.

AUM: Total gross AUM approximately €246 billion.

### 11.2. Portfolio Architecture and Analysis

#### Table 10: EQT Group Portfolio Analysis

## 12. Aqua-Spark

### 12.1. Fund Overview and Assets Under Management (AUM)

Aqua-Spark is a Dutch fund dedicated to sustainable aquaculture.

AUM: Approximately $500 million.

### 12.2. Portfolio Architecture and Analysis

#### Table 11: Aqua-Spark Portfolio Analysis

## 13. WP Global Partners

### 13.1. Fund Overview and Assets Under Management (AUM)

WP Global Partners is a private markets firm focused on small to middle-market buyouts, debt, and venture.

AUM: Approximately $3.1 billion.

### 13.2. Portfolio Analysis

#### Table 12: WP Global Partners Portfolio Analysis

## 14. Inflexion

### 14.1. Fund Overview and Assets Under Management (AUM)

Inflexion is a UK mid-market private equity firm.

AUM: Approximately £10 billion.

### 14.2. Portfolio Analysis

#### Table 13: Inflexion Portfolio Analysis

## 15. NovaQuest Capital Management

### 15.1. Fund Overview and Assets Under Management (AUM)

NovaQuest specializes in product finance and equity in biopharma/animal health.

AUM: Over $2.5 billion.

### 15.2. Portfolio Analysis

#### Table 14: NovaQuest Portfolio Analysis

## 16. Ocean 14 Capital

### 16.1. Fund Overview and Assets Under Management (AUM)

Ocean 14 Capital is a PE impact fund focused on SDG 14 (Life Below Water).

AUM: Target fund size €200 million.

### 16.2. Portfolio Analysis

#### Table 15: Ocean 14 Capital Portfolio Analysis

## 17. Fulcrum Global Capital (FGC)

### 17.1. Fund Overview and Assets Under Management (AUM)

Fulcrum Global Capital is a venture capital firm focused on the "Agriculture and Animal Health" sectors.

AUM: Approximately $150 million (Fund I + Fund II + Co-investments).

### 17.2. Portfolio Architecture and Analysis

#### Table 16: Fulcrum Global Capital Portfolio Analysis

## 18. Cavallo Ventures

### 18.1. Fund Overview and Assets Under Management (AUM)

Cavallo Ventures is the corporate venture capital arm of Wilbur-Ellis, a massive agricultural retail and marketing company.

AUM: Invests off the corporate balance sheet (Estimated deal flow supports multi-million dollar portfolio).

### 18.2. Portfolio Architecture and Analysis

#### Table 17: Cavallo Ventures Portfolio Analysis

## 19. Anterra Capital

### 19.1. Fund Overview and Assets Under Management (AUM)

Anterra Capital is an international food and ag-tech VC firm backed by Rabobank and Fidelity.

AUM: Approximately $500 million+ (Fund I + $260M Fund II).

### 19.2. Portfolio Architecture and Analysis

#### Table 18: Anterra Capital Portfolio Analysis

## 20. Nutreco (NuFrontiers)

### 20.1. Fund Overview and Assets Under Management (AUM)

NuFrontiers is the investment arm of Nutreco, a global leader in animal nutrition and aquafeed.

AUM: Strategic corporate investor (Balance sheet).

### 20.2. Portfolio Architecture and Analysis

#### Table 19: Nutreco (NuFrontiers) Portfolio Analysis

## 21. Blue Horizon

### 21.1. Fund Overview and Assets Under Management (AUM)

Blue Horizon is a pure-play impact investor in the future of food (alternative proteins).

AUM: Approximately $850 million+ (across Growth and Venture funds).

### 21.2. Portfolio Architecture and Analysis

#### Table 20: Blue Horizon Portfolio Analysis

## 22. Cibus Capital (Cibus Fund)

### 22.1. Fund Overview and Assets Under Management (AUM)

Cibus Capital invests in sustainable food and agriculture.

AUM: Approximately $1.3 billion.

### 22.2. Portfolio Architecture and Analysis

#### Table 21: Cibus Fund Portfolio Analysis

## 23. Vestar Capital Partners

### 23.1. Fund Overview and Assets Under Management (AUM)

Vestar Capital Partners is a middle-market private equity firm.

AUM: Approximately $3-4 billion (Total transaction value $60B+ over history).

### 23.2. Portfolio Architecture and Analysis

#### Table 22: Vestar Capital Partners Portfolio Analysis

## 24. Conclusion

The analysis of these additional funds reinforces the trends observed in the initial report. Cavallo and Nutreco represent the strategic corporate interest in securing future supply chains (insect protein, microbiome health). Blue Horizon and Stray Dog are driving the "alt-protein" revolution which is now heavily bleeding into pet food (Wild Earth, Bond Pet Foods). Meanwhile, PE giants like Vestar continue to acquire profitable, scalable consumer health brands (PetHonesty) that capitalize on the "pet humanization" trend. The ecosystem is maturing, with clear leaders emerging in insect protein (Protix, Enthos) and microbiome therapeutics (BiomEdit, Native Microbials).